newsfilter
← Latest News
Business Wire·

enGene Announces Proposed Public Offering of Common Shares

enGene Holdings Inc. (NASDAQ:ENGN, "enGene" or the "Company")), a clinical-stage, non-viral genetic medicines company, today announced that it has commenced an underwritten public offering of its common shares. All